Equibles does not estimate personal net worth.
Get an email with a short summary when Midland States Bancorp, Inc. publishes a filing, an earnings call transcript or a press release.
Get MSBI alertsJeff Ludwig is recorded as CEO at Midland States Bancorp, Inc. (MSBI). The proxy statement of Puma Biotechnology, Inc. reports total compensation of $1,476,167 for Jeff Ludwig in fiscal 2025, including a base salary of $264,880. Disclosed compensation is on record for 6 fiscal years. Jeff Ludwig has spoken on 8 earnings calls across 1 company, most recently for Midland States Bancorp, Inc. on July 29, 2022. Midland States Bancorp, Inc. is classified in the Banks - Regional industry within the Financial Services sector. Other leadership on record at Midland States Bancorp, Inc. includes Jeffrey Ludwig (CEO and Board Member), Jeffrey C. Smith (Chairman and Board Member), Claire A. Stack (CFO) and 7 others.
“I'm going to start on Slide 3 with the highlights of the second quarter.”
“I'm going to start on slide three with the highlights of the first quarter. As we expected, we saw a continuation of many of the positive trends we experienced in the second half of last year.”
“I'm going to start on Slide 3 with the highlights of the fourth quarter. We had a very productive quarter that capped an exceptional year for the company, which saw us improve our financial performance while also investing in ways that we believe will enable us to continue improving in the years to come.”
“Before we begin today, I have some sad news to share. Last week, we lost a beloved member of the Midland family when Leon Holschbach, our former President and CEO, passed away after a long battle with ALS.”
“We’re going to start on Slide 3 with the highlights of the second quarter.”
Proxy statement
Start not stated–2025-04-28
Last confirmed by a filing; no departure on record
Banks - Regional · Financial Services
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Puma Biotechnology, Inc. (PBYI) | Chief Commercial Officer | $264,880 | $1,476,167 |
| 2024 | Puma Biotechnology, Inc. (PBYI) | Chief Commercial Officer | $608,499 | $1,228,288 |
| 2023 | Puma Biotechnology, Inc. (PBYI) | Chief Commercial Officer | $596,568 | $1,381,848 |
| 2022 | Puma Biotechnology, Inc. (PBYI) | Chief Commercial Officer | $573,623 | $1,099,483 |
| 2021 | Puma Biotechnology, Inc. (PBYI) | Chief Commercial Officer | $562,375 | $1,602,043 |
| 2020 | Puma Biotechnology, Inc. (PBYI) | Chief Commercial Officer | $435,417 | $3,291,813 |
